Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Advanced magnetic resonance imaging (MRI) techniques hold the promise to capture upper motor neuron loss and extramotor brain changes in amyotrophic lateral sclerosis (ALS) and as such deliver biomarkers relevant to diagnosis, prognosis and monitoring disease progression. However, a correlation between imaging parameters and clinical metrics has thus far been inconsistent across studies. We discuss the contributing factors to this clinical-imaging correlation gap as well as its implications for future research.

Original publication

DOI

10.3109/21678421.2015.1051989

Type

Journal article

Journal

Amyotroph Lateral Scler Frontotemporal Degener

Publication Date

2015

Volume

16

Pages

524 - 529

Keywords

Amyotrophic Lateral Sclerosis, Anisotropy, Brain, Corpus Callosum, Humans, Magnetic Resonance Imaging, Motor Neurons, Pyramidal Tracts, Spinal Cord